HomeMDGL • NASDAQ
add
Madrigal Pharmaceuticals Inc
Previous close
$225.72
Day range
$221.81 - $227.21
Year range
$119.76 - $299.98
Market cap
4.84B USD
Avg Volume
213.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 14.64M | — |
Operating expense | 176.54M | 104.21% |
Net income | -151.97M | -77.12% |
Net profit margin | -1.04K | — |
Earnings per share | -7.10 | -51.39% |
EBITDA | -162.27M | -87.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.06B | 254.47% |
Total assets | 1.10B | 263.61% |
Total liabilities | 242.67M | 21.97% |
Total equity | 857.12M | — |
Shares outstanding | 21.71M | — |
Price to book | 5.71 | — |
Return on assets | -37.24% | — |
Return on capital | -41.81% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -151.97M | -77.12% |
Cash from operations | -134.94M | -79.19% |
Cash from investing | -122.10M | -3,171.65% |
Cash from financing | 134.12M | 212.42% |
Net change in cash | -122.92M | -240.39% |
Free cash flow | -92.10M | -109.17% |
About
Founded
2011
Headquarters
Website
Employees
376